Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult

Br J Cancer. 2014 Oct 14;111(8):1675-6. doi: 10.1038/bjc.2014.60. Epub 2014 Mar 18.

Authors

S Boeck¹, M Haas¹, S Ormanns², S Kruger¹, J T Siveke³, V Heinemann¹

Affiliations

¹ Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany.
² Department of Pathology, Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany.
³ Department of Internal Medicine II, Klinikum Rechts der Isar, Technical University of Munich, D-81377 Munich, Germany.

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma / drug therapy*
Animals
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Fibroblasts / pathology*
Humans
Male
Pancreatic Neoplasms / drug therapy*